{"id":66320,"date":"2025-07-03T15:36:36","date_gmt":"2025-07-03T15:36:36","guid":{"rendered":"https:\/\/www.stocktargetadvisor.com\/blog\/?p=66320"},"modified":"2025-07-03T15:58:36","modified_gmt":"2025-07-03T15:58:36","slug":"analyst-coverage-updates-july-3rd-2025","status":"publish","type":"post","link":"https:\/\/www.stocktargetadvisor.com\/blog\/analyst-coverage-updates-july-3rd-2025\/","title":{"rendered":"Analyst Coverage Updates: July 3rd, 2025"},"content":{"rendered":"<h2><a href=\"https:\/\/www.stocktargetadvisor.com\/blog\/?p=66320&amp;preview=true\">Analyst Ratings (USA)<\/a><\/h2>\n<p>4D Molecular Therapeutics (FDMT) is rated a Buy with a $25.00 target reiterated by Chardan Capital.<\/p>\n<p>Absci (ABSI) is initiated with an Overweight rating and a $7.00 target by Morgan Stanley.<\/p>\n<p>Advance Auto Parts (AAP) is rated Neutral with its target price raised to $44.00 by Mizuho.<\/p>\n<p>Advanced Micro Devices (AMD) is rated Outperform with its target price raised to $152.00 by Mizuho.<\/p>\n<p>AeroVironment (AVAV) is rated Outperform with its target raised to $275.00 by Royal Bank of Canada.<\/p>\n<p>AeroVironment (AVAV) is rated a Buy with a target updated to $275.00 by RBC Capital.<\/p>\n<p>Alphabet Class A (GOOGL) is rated Hold with its target updated to $160.00 by Loop Capital Markets.<\/p>\n<p>Ameriprise Financial (AMP) is rated Underweight with its target raised to $434.00 by Piper Sandler.<\/p>\n<p>Amplify Energy (AMPY) is rated a Buy, reiterated by Benchmark (target not disclosed).<\/p>\n<p>APi Group (APG) is rated a Buy with a $38.00 target by Truist Financial.<\/p>\n<p>Ardagh Metal Packaging (AMBP) is rated a Buy with its target raised to $5.00 by Citigroup.<\/p>\n<p>argenx (ARGX) is initiated with an Overweight rating and a $700.00 target by Morgan Stanley.<\/p>\n<p>ARM (ARM) is rated Outperform with its target raised to $180.00 by Mizuho.<\/p>\n<p>ARM Holdings PLC ADR (ARM) is rated a Buy with a $180.00 target updated by Mizuho Securities.<\/p>\n<p>Ascendis Pharma A\/S (ASND) is initiated with an Overweight rating and a $250.00 target by Morgan Stanley.<\/p>\n<p>Astrana Health (ASTH) is rated a Buy with its target price updated to $40.00 by TD Cowen.<\/p>\n<p>Atlantic Union Bankshares (AUB) is rated Hold with its target price updated to $35.00 by Morgan Stanley.<\/p>\n<p>AutoZone (AZO) is rated Outperform with its target raised to $4,050.00 by Mizuho.<\/p>\n<p>Axsome Therapeutics (AXSM) is initiated with an Overweight rating and a $190.00 target by Morgan Stanley.<\/p>\n<p>Ball (BALL) is rated Neutral with its target raised to $63.00 by Citigroup.<\/p>\n<p>Bank OZK (OZK) is rated Hold with its target price updated to $55.00 by Morgan Stanley.<\/p>\n<p>Belite Bio (BLTE) is rated a Buy with its $100.00 target reiterated by HC Wainwright.<\/p>\n<p>BioMarin Pharmaceutical (BMRN) is initiated with an Overweight rating and a $97.00 target by Morgan Stanley.<\/p>\n<p>BlackRock (BLK) is rated Overweight with its target raised to $1,180.00 by Wells Fargo &amp; Company.<\/p>\n<p>Brighthouse Financial (BHF) is rated Neutral with its target lowered to $55.00 by Piper Sandler.<\/p>\n<p>BrightView (BV) is rated a Buy with its target lowered to $20.00 by Loop Capital.<\/p>\n<p>BrightView Holdings (BV) is rated a Buy with a $20.00 target updated by Loop Capital Markets.<\/p>\n<p>Broadcom (AVGO) is rated Outperform with its target raised to $315.00 by Mizuho.<\/p>\n<p>C.H. Robinson Worldwide (CHRW) is rated a Buy with its target lowered to $129.00 by UBS Group.<\/p>\n<p>Cadence Bank (CADE) is rated a Buy with its target updated to $38.00 by Morgan Stanley.<\/p>\n<p>CarGurus (CARG) is rated Neutral with its target lowered to $37.00 by Citigroup.<\/p>\n<p>CarMax (KMX) is rated Neutral with its target lowered to $78.00 by Mizuho.<\/p>\n<p>Celanese (CE) is rated Sector Perform, reiterated by Royal Bank of Canada (target not disclosed).<\/p>\n<p>Celanese (CE) is rated Hold with its target updated to $63.00 by RBC Capital.<\/p>\n<p>Certara (CERT) is initiated with an Equal Weight rating and a $16.00 target by Morgan Stanley.<\/p>\n<p>CH Robinson (CHRW) is rated a Buy with a $129.00 target by UBS.<\/p>\n<p>Chemours Company (CC) is rated a Buy with its $15.00 target updated by RBC Capital.<\/p>\n<p>Citigroup (C) is rated a Buy with its $103.00 target updated by Morgan Stanley.<\/p>\n<p>Citizens (CIZN) is rated Market Perform, reiterated by Citigroup (target not disclosed).<\/p>\n<p>Citizens Financial (CFG) is rated Hold with its target updated to $53.00 by Morgan Stanley.<\/p>\n<p>CME Group (CME) is rated Neutral with its target raised to $275.00 by Citigroup.<\/p>\n<p>Comerica (CMA) is rated Sell with its target updated to $61.00 by Morgan Stanley.<\/p>\n<p>Commerce Bancshares (CBSH) is rated Hold with its target updated to $66.00 by Morgan Stanley.<\/p>\n<p>Constellation Brands (STZ) is rated Buy with its $205.00 target reiterated by UBS Group.<\/p>\n<p>Constellation Brands (STZ) is rated Neutral with its target raised to $174.00 by Citigroup.<\/p>\n<p>Constellation Brands (STZ) is rated Buy with its $200.00 target updated by Needham &amp; Company LLC.<\/p>\n<p>Constellation Brands (STZ) is rated Neutral with its $182.00 target updated by JPMorgan Chase &amp; Co.<\/p>\n<p>Constellation Brands (STZ) is rated Neutral with its $182.00 target updated by Bank of America.<\/p>\n<p>Core Natural Resources (CNR) is rated Buy with its target lowered to $78.00 by UBS Group.<\/p>\n<p>Core Natural Resources (CNR) is rated Buy with its target updated to $78.00 by UBS.<\/p>\n<p>Corebridge Financial (CRBG) is rated Overweight with its target raised to $40.00 by Piper Sandler.<\/p>\n<p>Costco (COST) is rated Buy with its $1,100.00 target updated by Telsey Advisory.<\/p>\n<p>Costco Wholesale (COST) is rated Outperform with its $1,100.00 target reiterated by Telsey Advisory Group.<\/p>\n<p>Crane NXT (CXT) is rated Hold with its target updated to $57.00 by Northland Securities.<\/p>\n<p>Credo Technology Group (CRDO) is rated Outperform with its target raised to $98.00 by Mizuho.<\/p>\n<p>CrowdStrike Holdings (CRWD) is rated Buy with its $575.00 target updated by Wedbush.<\/p>\n<p>Crown (CCK) is rated Buy with its target raised to $129.00 by Citigroup.<\/p>\n<p>Cullen\/Frost Bankers (CFR) is rated Sell with its target updated to $125.00 by Morgan Stanley.<\/p>\n<p>Cullinan Management (CGEM) is rated Buy with its $22.00 target updated by Clear Street.<\/p>\n<p>Datadog (DDOG) is rated Buy with its $130.00 target updated by Scotiabank.<\/p>\n<p>Datadog (DDOG) is rated Buy with its $170.00 target updated by Wedbush.<\/p>\n<p>Disc Medicine (IRON) is rated a Buy with a $118.00 target reiterated by HC Wainwright.<\/p>\n<p>Disc Medicine (IRON) is rated an Overweight with an $85.00 target initiated by Morgan Stanley.<\/p>\n<p>DraftKings (DKNG) is rated a Buy with target lowered to $53.00 by Jefferies Financial Group.<\/p>\n<p>Ducommun (DCO) is rated an Outperform with target raised to $95.00 by Royal Bank of Canada.<\/p>\n<p>Ducommun (DCO) is rated a Buy with target updated to $95.00 by RBC Capital.<\/p>\n<p>DuPont de Nemours (DD) is rated a Buy with target raised to $85.00 by Citigroup.<\/p>\n<p>DuPont de Nemours (DD) is rated a Buy with target updated to $82.00 by Argus Research.<\/p>\n<p>East West Bancorp (EWBC) is rated a Hold with target updated to $111.00 by Morgan Stanley.<\/p>\n<p>Ecolab (ECL) is rated a Buy with target raised to $325.00 by Citigroup.<\/p>\n<p>Embraer SA (ERJ) is rated a Buy with target updated to $65.00 by Bank of America Securities.<\/p>\n<p>Equinix (EQIX) is rated a Buy with target reiterated by Cowen (target price not disclosed).<\/p>\n<p>Fastenal Company (FAST) is rated a Hold with target updated to $43.00 by Morgan Stanley.<\/p>\n<p>FedEx (FDX) is upgraded to Outperform with a $270.00 target by BNP Paribas Exane.<\/p>\n<p>Fifth Third Bancorp (FITB) is rated a Hold with target updated to $47.00 by Morgan Stanley.<\/p>\n<p>Franco-Nevada (FNV) is rated a Buy with target raised to $210.00 by UBS Group.<\/p>\n<p>Franklin Covey (FC) is rated an Outperform with a $35.00 target reiterated by Barrington Research.<\/p>\n<p>Franklin Covey Company (FC) is rated a Buy with $37.00 target updated by Northland Securities.<\/p>\n<p>Franklin Covey Company (FC) is rated a Buy with $35.00 target updated by Barrington.<\/p>\n<p>Gain Therapeutics (GANX) is rated a Buy with $8.00 target reiterated by HC Wainwright.<\/p>\n<p>Gambling.com Group (GAMB) is rated a Buy with target lowered to $18.00 by Jefferies Financial Group.<\/p>\n<p>Goldman Sachs Group (GS) is rated a Hold with target updated to $680.00 by Morgan Stanley.<\/p>\n<p>Heico (HEI) is rated a Buy with target raised to $355.00 by Bank of America.<\/p>\n<p>Hewlett Packard Enterprise (HPE) is rated an Equal Weight with target raised to $22.00 by Wells Fargo &amp; Company.<\/p>\n<p>Hewlett Packard Enterprise (HPE) is rated an Overweight with target raised to $26.00 by Barclays.<\/p>\n<p>HIVE Digital Technologies (HIVE) is rated a Buy with $9.00 target reiterated by Canaccord Genuity Group.<\/p>\n<p>Honest Company (HNST) is rated a Buy with target updated to $8.00 by Northland Securities.<\/p>\n<p>Horace Mann Educators (HMN) is rated a Neutral with target raised to $45.00 by Piper Sandler.<\/p>\n<p>Huntington Bancshares (HBAN) is upgraded to Outperform with a $21.00 target by Wolfe Research.<\/p>\n<p>Huntington Bancshares (HBAN) is rated a Buy with $19.00 target updated by Morgan Stanley.<\/p>\n<p>Inmune Bio (INMB) is rated a Buy with target updated to $7.00 by Alliance Global Partners.<\/p>\n<p>Intel (INTC) is rated a Neutral with target raised to $23.00 by Mizuho.<\/p>\n<p>JPMorgan Chase (JPM) is rated a Hold with target updated to $296.00 by Morgan Stanley.<\/p>\n<p>Karman (KRMN) is rated an Outperform with target raised to $51.00 by Royal Bank of Canada.<\/p>\n<p>Karman Holdings Inc. (KRMN) is rated a Buy with target updated to $51.00 by RBC Capital.<\/p>\n<p>KeyCorp (KEY) is rated a Hold with target updated to $20.00 by Morgan Stanley.<\/p>\n<p>KKR &amp; Co (KKR) is rated a Buy with target updated to $150.00 by Piper Sandler.<\/p>\n<p>KNOT Offshore Partners (KNOP) is rated a Buy with target updated to $12.00 by Alliance Global Partners.<\/p>\n<p>Kratos Defense (KTOS) is rated a Buy with target updated to $50.00 by RBC Capital.<\/p>\n<p>Kratos Defense &amp; Security (KTOS) had its target set at $54.00 by Stifel Nicolaus (rating not disclosed).<\/p>\n<p>Kymera Therapeutics (KYMR) is rated an Overweight with a $70.00 target initiated by Morgan Stanley.<\/p>\n<p>Leslie&#8217;s (LESL) is rated a Neutral with target lowered to $1.00 by Mizuho.<\/p>\n<p>Levi Strauss &amp; Co (LEVI) is rated a Buy with target updated to $21.00 by Telsey Advisory.<\/p>\n<p>Levi Strauss &amp; Co. (LEVI) is rated an Outperform with $21.00 target reiterated by Telsey Advisory Group.<\/p>\n<p>LyondellBasell (LYB) is rated a Hold with target updated to $64.00 by RBC Capital.<\/p>\n<p>M&amp;T Bank (MTB) is rated a Buy with target updated to $236.00 by Morgan Stanley.<\/p>\n<p>Merchants Bancorp (MBIN) is rated a Hold with target updated to $40.00 by Morgan Stanley.<\/p>\n<p>Mercury Systems (MRCY) is rated a Hold with target updated to $55.00 by RBC Capital.<\/p>\n<p>Meta Platforms (META) is upgraded to Hold by Needham &amp; Company LLC (target price not disclosed).<\/p>\n<p>Meta Platforms (META) is rated a Buy with target updated to $750.00 by Citizens JMP.<\/p>\n<p>Mogo (MOGO) is rated a Buy with $4.00 target reiterated by HC Wainwright.<\/p>\n<p>Moody&#8217;s (MCO) is rated an Overweight with target raised to $573.00 by Wells Fargo &amp; Company.<\/p>\n<p>Newmont (NEM) is rated a Buy with target raised to $68.00 by UBS Group.<\/p>\n<p>Newmont Mining (NEM) is rated a Buy with target updated to $67.00 by Raymond James.<\/p>\n<p>Newmont Mining (NEM) is rated a Buy with target updated to $68.00 by UBS.<\/p>\n<p>NioCorp Developments (NB) is rated a Buy with target lowered to $4.00 by HC Wainwright.<\/p>\n<p>Northern Trust (NTRS) is rated a Hold with target raised to $126.00 by Truist Financial.<\/p>\n<p>NV5 Global (NVEE) is rated a Hold with target reiterated by Maxim Group at $23.<\/p>\n<p>NVIDIA (NVDA) is rated an Outperform with target raised to $185.00 by Mizuho.<\/p>\n<p>O-I Glass (OI) is rated a Neutral with target raised to $16.00 by Citigroup.<\/p>\n<p>Olin (OLN) is rated a Hold with target updated to $23.00 by RBC Capital.<\/p>\n<p>ONEOK (OKE) is rated an Overweight with target raised to $97.00 by JPMorgan Chase &amp; Co.<\/p>\n<p>Oneok (OKE) is rated a Buy with target updated to $97.00 by J.P. Morgan.<\/p>\n<p>Oracle (ORCL) is rated a Buy with target raised to $275.00 by TD Cowen.<\/p>\n<p>Penguin Solutions (PENG) is rated a Buy with target reiterated to $27.00 by Rosenblatt Securities.<\/p>\n<p>PNC Financial (PNC) is rated a Sell with target updated to $179.00 by Morgan Stanley.<\/p>\n<p>PNC Financial Services (PNC) is rated a Peer Perform with target reiterated by Wolfe Research (target not disclosed).<\/p>\n<p>Polaris (PII) is rated a Neutral with target raised to $46.00 by Robert W. Baird.<\/p>\n<p>Polaris (PII) is rated a Hold with target updated to $46.00 by Robert W. Baird.<\/p>\n<p>Prairie Operating (PROP) is initiated with a Sector Weight rating by KeyCorp (target not disclosed).<\/p>\n<p>Praxis Precision Medicines (PRAX) is rated a Buy with target updated to $61.00 by TD Cowen.<\/p>\n<p>Primoris Services (PRIM) is initiated with a Buy rating and $102.00 target by Janney Montgomery Scott.<\/p>\n<p>Principal Financial Group (PFG) is rated an Overweight with target raised to $89.00 by Piper Sandler.<\/p>\n<p>Prosperity Bancshares (PB) is rated a Buy with target updated to $83.00 by Morgan Stanley.<\/p>\n<p>Recursion Pharmaceuticals (RXRX) is initiated with an Equal Weight rating and $5.00 target by Morgan Stanley.<\/p>\n<p>Regeneron (REGN) is rated a Buy with target updated to $800.00 by TD Cowen.<\/p>\n<p>Regions Financial (RF) is rated a Hold with target updated to $27.00 by Morgan Stanley.<\/p>\n<p>Replimune Group (REPL) is rated a Buy with target updated to $22.00 by H.C. Wainwright.<\/p>\n<p>Rio Tinto (RIO) is rated a Hold with target updated to $62.00 by Berenberg Bank.<\/p>\n<p>Rush Street Interactive (RSI) is rated a Buy with target raised to $18.00 by Jefferies Financial Group.<\/p>\n<p>S&amp;P Global (SPGI) is rated an Overweight with target raised to $632.00 by Wells Fargo &amp; Company.<\/p>\n<p>Sana Biotechnology (SANA) is initiated with an Overweight rating and $12.00 target by Morgan Stanley.<\/p>\n<p>Sanofi (SNY) is rated a Hold with target updated to $60.00 by Goldman Sachs.<\/p>\n<p>Schrodinger (SDGR) is initiated with an Equal Weight rating and $28.00 target by Morgan Stanley.<\/p>\n<p>Sensient Technologies (SXT) is rated an Outperform with target updated to $125.00 by Robert W. Baird.<\/p>\n<p>SkyWater Technology (SKYT) is rated a Buy with target updated to $12.00 by TD Cowen.<\/p>\n<p>Snowflake (SNOW) is rated a Buy with target updated to $245.00 by Monness.<\/p>\n<p>Southern Copper (SCCO) is rated a Neutral with target lowered to $79.00 by JPMorgan Chase &amp; Co.<\/p>\n<p>Southern Copper (SCCO) is rated a Hold with target updated to $79.00 by J.P. Morgan.<\/p>\n<p>Sportradar Group (SRAD) is rated a Buy with target raised to $32.00 by Jefferies Financial Group.<\/p>\n<p>State Street (STT) is rated a Buy with target raised to $122.00 by Truist Financial.<\/p>\n<p>State Street (STT) is rated a Buy with target updated to $122.00 by Truist Financial.<\/p>\n<p>Super Micro Computer (SMCI) is rated a Neutral with target raised to $47.00 by Mizuho.<\/p>\n<p>Synovus (SNV) is rated a Hold with target updated to $58.00 by Morgan Stanley.<\/p>\n<p>Telix Pharmaceuticals (TLX) is rated a Buy with target updated to $23.00 by HC Wainwright.<\/p>\n<p>TeraWulf Inc (WULF) is rated a Buy with target updated to $6.00 by Rosenblatt Securities.<\/p>\n<p>Tesla (TSLA) is rated a Sell with $120.00 target updated by HSBC.<\/p>\n<p>Tesla (TSLA) is rated a Hold with target updated to $280.00 by Truist Financial.<\/p>\n<p>Tesla (TSLA) is rated a Hold with target updated to $315.00 by Goldman Sachs.<\/p>\n<p>Theratechnologies (THTX) is rated a Hold with target updated by Jones Trading (target not disclosed).<\/p>\n<p>TPG RE Finance (TRTX) is rated a Buy with target updated to $10.00 by Citizens JMP.<\/p>\n<p>Truist Financial (TFC) is rated a Hold with target updated to $47.00 by Morgan Stanley.<\/p>\n<p>Trupanion (TRUP) is rated an Overweight with target updated to $62.00 by Piper Sandler.<\/p>\n<p>Two Harbors Investments (TWO) is rated a Market Perform with target updated by Citizens JMP (target not disclosed).<\/p>\n<p>Two Harbors Investments (TWO) is rated a Market Perform with target updated by JMP Securities (target not disclosed).<\/p>\n<p>UMB Financial (UMBF) is rated a Buy with target updated to $120.00 by Morgan Stanley.<\/p>\n<p>UniFirst (UNF) is rated a Hold with target updated to $194.00 by UBS.<\/p>\n<p>United Parcel (UPS) is rated a Hold with target updated to $100.00 by Exane BNP Paribas.<\/p>\n<p>United Parcel Service (UPS) is rated a Neutral with target updated to $100.00 by BNP Paribas Exane.<\/p>\n<p>Unum Group (UNM) is rated an Overweight with target updated to $92.00 by Piper Sandler.<\/p>\n<p>US Bancorp (USB) is rated a Buy with target updated to $51.00 by Morgan Stanley.<\/p>\n<p>Valley National Bancorp (VLY) is rated an Overweight with target updated to $11.00 by Morgan Stanley.<\/p>\n<p>Veritone (VERI) is rated a Buy with target updated to $4.00 by D. Boral Capital.<\/p>\n<p>Vista Oil &amp; Gas SAB de CV (VIST) is rated a Buy with target updated to $75.00 by Bank of America Securities.<\/p>\n<p>Vital Farms (VITL) is rated a Buy with target updated to $50.00 by Lake Street.<\/p>\n<p>Warner Music Group (WMG) is rated an Outperform with target updated to $34.00 by Sanford C. Bernstein.<\/p>\n<p>Webster Financial (WBS) is rated a Hold with target updated to $64.00 by Morgan Stanley.<\/p>\n<p>Westlake Corporation (WLK) is rated a Buy with target updated to $92.00 by RBC Capital.<\/p>\n<p>Xponential Fitness (XPOF) is rated a Buy with target updated to $16.00 by Lake Street.<\/p>\n<p>Xponential Fitness (XPOF) is rated a Buy with target updated to $13.00 by Guggenheim.<\/p>\n<p>Zions Bancorporation NA (ZION) is rated a Hold with target updated to $60.00 by Morgan Stanley.<\/p>\n<p>Zymeworks (ZYME) is rated a Neutral with target updated to $13.00 by HC Wainwright.<\/p>\n<div class=\"flex basis-auto flex-col -mb-(--composer-overlap-px) [--composer-overlap-px:55px] grow overflow-hidden\">\n<div class=\"relative h-full\">\n<div class=\"flex h-full flex-col overflow-y-auto [scrollbar-gutter:stable_both-edges] @[84rem]\/thread:pt-(--header-height)\">\n<div class=\"@thread-xl\/thread:pt-header-height flex flex-col text-sm pb-25\">\n<article class=\"text-token-text-primary w-full\" dir=\"auto\" data-testid=\"conversation-turn-30\" data-scroll-anchor=\"true\">\n<div class=\"text-base my-auto mx-auto py-5 [--thread-content-margin:--spacing(4)] @[37rem]:[--thread-content-margin:--spacing(6)] @[72rem]:[--thread-content-margin:--spacing(16)] px-(--thread-content-margin)\">\n<div class=\"[--thread-content-max-width:32rem] @[34rem]:[--thread-content-max-width:40rem] @[64rem]:[--thread-content-max-width:48rem] mx-auto flex max-w-(--thread-content-max-width) flex-1 text-base gap-4 md:gap-5 lg:gap-6 group\/turn-messages focus-visible:outline-hidden\" tabindex=\"-1\">\n<div class=\"group\/conversation-turn relative flex w-full min-w-0 flex-col agent-turn\">\n<div class=\"relative flex-col gap-1 md:gap-3\">\n<div class=\"flex max-w-full flex-col grow\">\n<div class=\"min-h-8 text-message relative flex w-full flex-col items-end gap-2 text-start break-words whitespace-normal [.text-message+&amp;]:mt-5\" dir=\"auto\" data-message-author-role=\"assistant\" data-message-id=\"29ad5e24-f321-4b76-8f7f-377ee6ac60ee\" data-message-model-slug=\"gpt-4-1-mini\">\n<div class=\"flex w-full flex-col gap-1 empty:hidden first:pt-[3px]\">\n<div class=\"markdown prose dark:prose-invert w-full break-words light\"><\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/article>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Analyst Ratings (USA) 4D Molecular Therapeutics (FDMT) is rated a Buy with a $25.00 target reiterated by Chardan Capital. Absci (ABSI) is initiated with an&#8230;<\/p>\n","protected":false},"author":3,"featured_media":66324,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"image","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-66320","post","type-post","status-publish","format-image","has-post-thumbnail","hentry","category-blog","post_format-post-format-image"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v19.4 (Yoast SEO v21.4) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Analyst Coverage Updates: July 3rd, 2025 | Stock Target Advisor<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.stocktargetadvisor.com\/blog\/analyst-coverage-updates-july-3rd-2025\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Analyst Coverage Updates: July 3rd, 2025\" \/>\n<meta property=\"og:description\" content=\"Analyst Ratings (USA) 4D Molecular Therapeutics (FDMT) is rated a Buy with a $25.00 target reiterated by Chardan Capital. Absci (ABSI) is initiated with an...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.stocktargetadvisor.com\/blog\/analyst-coverage-updates-july-3rd-2025\/\" \/>\n<meta property=\"og:site_name\" content=\"Stock Target Advisor\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/StockTargetAdvisor\/\" \/>\n<meta property=\"article:published_time\" content=\"2025-07-03T15:36:36+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-07-03T15:58:36+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.stocktargetadvisor.com\/blog\/wp-content\/uploads\/2025\/07\/arm-holdings.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"901\" \/>\n\t<meta property=\"og:image:height\" content=\"547\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"STA Research\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@AdvisorTarget\" \/>\n<meta name=\"twitter:site\" content=\"@AdvisorTarget\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"STA Research\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"12 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/analyst-coverage-updates-july-3rd-2025\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/analyst-coverage-updates-july-3rd-2025\/\"},\"author\":{\"name\":\"STA Research\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae\"},\"headline\":\"Analyst Coverage Updates: July 3rd, 2025\",\"datePublished\":\"2025-07-03T15:36:36+00:00\",\"dateModified\":\"2025-07-03T15:58:36+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/analyst-coverage-updates-july-3rd-2025\/\"},\"wordCount\":2590,\"commentCount\":38,\"publisher\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\"},\"articleSection\":[\"Market News &amp; Insights\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.stocktargetadvisor.com\/blog\/analyst-coverage-updates-july-3rd-2025\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/analyst-coverage-updates-july-3rd-2025\/\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/analyst-coverage-updates-july-3rd-2025\/\",\"name\":\"Analyst Coverage Updates: July 3rd, 2025 | Stock Target Advisor\",\"isPartOf\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#website\"},\"datePublished\":\"2025-07-03T15:36:36+00:00\",\"dateModified\":\"2025-07-03T15:58:36+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/analyst-coverage-updates-july-3rd-2025\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.stocktargetadvisor.com\/blog\/analyst-coverage-updates-july-3rd-2025\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/analyst-coverage-updates-july-3rd-2025\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Analyst Coverage Updates: July 3rd, 2025\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#website\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\",\"name\":\"Stock Target Advisor\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.stocktargetadvisor.com\/blog\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\",\"name\":\"Stock Target Advisor\",\"alternateName\":\"STA\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/\",\"url\":\"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg\",\"contentUrl\":\"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg\",\"width\":\"225\",\"height\":\"225\",\"caption\":\"Stock Target Advisor\"},\"image\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/StockTargetAdvisor\/\",\"https:\/\/twitter.com\/AdvisorTarget\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae\",\"name\":\"STA Research\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g\",\"caption\":\"STA Research\"},\"description\":\"STA Research (StockTargetAdvisor.com) is a independent Investment Research company that specializes in stock forecasting and analysis with integrated AI, based on our platform stocktargetadvisor.com, EST 2007.\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/author\/sta-research\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Analyst Coverage Updates: July 3rd, 2025 | Stock Target Advisor","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.stocktargetadvisor.com\/blog\/analyst-coverage-updates-july-3rd-2025\/","og_locale":"en_US","og_type":"article","og_title":"Analyst Coverage Updates: July 3rd, 2025","og_description":"Analyst Ratings (USA) 4D Molecular Therapeutics (FDMT) is rated a Buy with a $25.00 target reiterated by Chardan Capital. Absci (ABSI) is initiated with an...","og_url":"https:\/\/www.stocktargetadvisor.com\/blog\/analyst-coverage-updates-july-3rd-2025\/","og_site_name":"Stock Target Advisor","article_publisher":"https:\/\/www.facebook.com\/StockTargetAdvisor\/","article_published_time":"2025-07-03T15:36:36+00:00","article_modified_time":"2025-07-03T15:58:36+00:00","og_image":[{"width":901,"height":547,"url":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-content\/uploads\/2025\/07\/arm-holdings.webp","type":"image\/webp"}],"author":"STA Research","twitter_card":"summary_large_image","twitter_creator":"@AdvisorTarget","twitter_site":"@AdvisorTarget","twitter_misc":{"Written by":"STA Research","Est. reading time":"12 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/analyst-coverage-updates-july-3rd-2025\/#article","isPartOf":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/analyst-coverage-updates-july-3rd-2025\/"},"author":{"name":"STA Research","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae"},"headline":"Analyst Coverage Updates: July 3rd, 2025","datePublished":"2025-07-03T15:36:36+00:00","dateModified":"2025-07-03T15:58:36+00:00","mainEntityOfPage":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/analyst-coverage-updates-july-3rd-2025\/"},"wordCount":2590,"commentCount":38,"publisher":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization"},"articleSection":["Market News &amp; Insights"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.stocktargetadvisor.com\/blog\/analyst-coverage-updates-july-3rd-2025\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/analyst-coverage-updates-july-3rd-2025\/","url":"https:\/\/www.stocktargetadvisor.com\/blog\/analyst-coverage-updates-july-3rd-2025\/","name":"Analyst Coverage Updates: July 3rd, 2025 | Stock Target Advisor","isPartOf":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#website"},"datePublished":"2025-07-03T15:36:36+00:00","dateModified":"2025-07-03T15:58:36+00:00","breadcrumb":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/analyst-coverage-updates-july-3rd-2025\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.stocktargetadvisor.com\/blog\/analyst-coverage-updates-july-3rd-2025\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/analyst-coverage-updates-july-3rd-2025\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.stocktargetadvisor.com\/blog\/"},{"@type":"ListItem","position":2,"name":"Analyst Coverage Updates: July 3rd, 2025"}]},{"@type":"WebSite","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#website","url":"https:\/\/www.stocktargetadvisor.com\/blog\/","name":"Stock Target Advisor","description":"","publisher":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.stocktargetadvisor.com\/blog\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization","name":"Stock Target Advisor","alternateName":"STA","url":"https:\/\/www.stocktargetadvisor.com\/blog\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/","url":"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg","contentUrl":"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg","width":"225","height":"225","caption":"Stock Target Advisor"},"image":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/StockTargetAdvisor\/","https:\/\/twitter.com\/AdvisorTarget"]},{"@type":"Person","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae","name":"STA Research","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g","caption":"STA Research"},"description":"STA Research (StockTargetAdvisor.com) is a independent Investment Research company that specializes in stock forecasting and analysis with integrated AI, based on our platform stocktargetadvisor.com, EST 2007.","url":"https:\/\/www.stocktargetadvisor.com\/blog\/author\/sta-research\/"}]}},"_links":{"self":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/66320","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/comments?post=66320"}],"version-history":[{"count":7,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/66320\/revisions"}],"predecessor-version":[{"id":66329,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/66320\/revisions\/66329"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/media\/66324"}],"wp:attachment":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/media?parent=66320"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/categories?post=66320"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/tags?post=66320"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}